Brain injury markers found in the blood months after COVID-19 infection

A new study published today (22 December 2023) in Nature Communications details that markers of brain injury are present in the blood many months after COVID-19 infection, despite inflammation blood tests being normal.

Vicore licenses idiopathic pulmonary fibrosis therapy to Nippon in Japan

Share this article Nippon will hold exclusive rights to develop and commercialise Vicore’s C21 in Japan, as per the agreement. Image Credit: FocusStocker / Shutterstock.

February 9, 2024

Over 50% of U.S. Adults Qualify for Ozempic, Wegovy

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated. Among 25,531 participants in the National Health

November 19, 2024

What are the minimal clinically important differences in the Diabetes Distress Scale–17 and its four subscales?

Adistribution-based minimal clinically important difference (MCID) for the Diabetes Distress Scale–17 (DDS-17) and its four subscales.

November 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.